Wissenschaftliche Arbeiten

Doç. Dr. Osman Köstek

197 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil
  1. Author`s Reply.

    PubMed, 2021

    PMID 35899300 Quelle: OpenAlex

  2. Is lymph node dissection necessary for staging while undergoing nephrectomy in patients with renal cell carcinoma?

    Current Problems in Cancer, 2020

    DOI 10.1016/j.currproblcancer.2020.100619 PMID 32800688 5 Zitationen (Europe PMC) Quelle: OpenAlex

  3. Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology?

    Current Problems in Cancer, 2020

    DOI 10.1016/j.currproblcancer.2020.100670 PMID 33129567 1 Zitation (Europe PMC) Quelle: OpenAlex

  4. Abstract P5-11-19: Ribociclib for the treatment of hormone receptor-positive refractory advanced breast cancer: Managed access programme in Turkey

    Cancer Research, 2020

    DOI 10.1158/1538-7445.sabcs19-p5-11-19 Quelle: OpenAlex

  5. The relationship between FDG PET/CT-defined metabolic parameters and the histopathological subtype of oesophageal carcinomas

    Polish Journal of Radiology, 2020

    DOI 10.5114/pjr.2020.95945 PMID 32612724 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  6. Prognostic Effect of Albumin-Bilirubin Grade on Survival in Advance Gastric Cancer Patients with de-novo Liver Metastasis

    Journal of Oncological Sciences, 2020

    DOI 10.37047/jos.2020-77649 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  7. Contrast nephropathy in cancer patients receiving anti-VEGF therapy: a prospective study

    International Journal of Clinical Oncology, 2020

    DOI 10.1007/s10147-020-01729-3 PMID 32591963 3 Zitationen (Europe PMC) Quelle: OpenAlex

  8. Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey.

    PubMed, 2020

    PMID 33099930 5 Zitationen (Europe PMC) Quelle: OpenAlex

  9. Comparison of Neoadjuvant Chemotherapy and Bladder-Preserving Chemoradiation in Patients with Non-Metastatic, Muscle-Invasive Bladder Cancer: A Single-Center Experience

    Journal of Oncological Sciences, 2020

    DOI 10.37047/jos.2020-77532 Frei zugänglicher VolltextQuelle: OpenAlex

  10. Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences

    European Urology Focus, 2020

    DOI 10.1016/j.euf.2020.09.010 PMID 33008789 8 Zitationen (Europe PMC) Quelle: ORCID

  11. Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma?

    Cureus, 2020

    DOI 10.7759/cureus.10525 PMID 33094066 6 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  12. Comparing Late-line Treatment Sequence of Regorafenib and Reduced-intensity FOLFOXIRI for Refractory Metastatic Colorectal Cancer

    American Journal of Clinical Oncology: Cancer Clinical Trials, 2020

    DOI 10.1097/coc.0000000000000759 PMID 33492837 Quelle: ORCID

  13. Does celiac disease impair coronary microvascular circulation: Coronary flow velocity reserve of patients with celiac disease

    Echocardiography, 2020

    DOI 10.1111/echo.14554 PMID 31816123 4 Zitationen (Europe PMC) Quelle: ORCID

  14. Introduction of a novel quantitative scoring system for acanthosis nigricans and its validation in a pilot study

    Dermatologic Therapy, 2020

    DOI 10.1111/dth.14450 PMID 33103332 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  15. Sarcopenia and Inflammation with Immunotherapy

    Oncologist, 2020

    DOI 10.1634/theoncologist.2019-1005 PMID 32191391 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  16. T helper 1 cytokines and their relationship with beta cell function in type 1 diabetes,T helper 1 sitokinleri ve tip 1 diyabette beta hücre fonksiyonu ile ilişkileri

    Turkish Journal of Endocrinology and Metabolism, 2020

    DOI 10.25179/tjem.2019-71070 Frei zugänglicher VolltextQuelle: ORCID

  17. Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experience.

    Journal of Clinical Oncology, 2020

    DOI 10.1200/jco.2020.38.6_suppl.451 3 Zitationen (OpenAlex) Quelle: OpenAlex

  18. 781P Prognostic factors in patients with metastatic urothelial carcinoma who have been treated with atezolizumab

    Annals of Oncology, 2020

    DOI 10.1016/j.annonc.2020.08.853 Frei zugänglicher VolltextQuelle: OpenAlex

  19. Real life data from Turkey regarding the impact of first-line sunitinib and pazopanib in metastatic renal cell cancer.

    Journal of Clinical Oncology, 2019

    DOI 10.1200/jco.2019.37.15_suppl.e16075 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  20. Is the prognostic nutritional index a prognostic and predictive factor in metastatic non-small cell lung cancer patients treated with first-line chemotherapy?

    Supportive Care in Cancer, 2019

    DOI 10.1007/s00520-019-05055-x PMID 31471631 15 Zitationen (Europe PMC) Quelle: OpenAlex

  21. Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer

    Cancer Chemotherapy and Pharmacology, 2019

    DOI 10.1007/s00280-019-03779-5 PMID 30680522 8 Zitationen (Europe PMC) Quelle: OpenAlex

  22. Comparison of skeletal muscle mass loss in patients with metastatic colorectal cancer treated with regorafenib or TAS-102.

    PubMed, 2019

    PMID 31786894 7 Zitationen (Europe PMC) Quelle: OpenAlex

  23. Is the Charlson Comorbidity Index a Prognostic Indicator for Toxicity and Mortality in Elderly Patients with Locally Advanced Rectal Cancer?

    PubMed, 2019

    PMID 31256595 5 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  24. The albumin-bilirubin (ALBI) grade as a significant prognostic factor in colorectal cancer patients with liver metastases

    Journal of Surgery and Medicine, 2019

    DOI 10.28982/josam.597751 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  25. Kastrasyon Dirençli Metastatik Prostat Kanseri (Kdmpk) Olan Geriatrik (≥75 Yaş) Hastalarda 1. Basamak Dosetaksel Tedavi Sonuçları- Gerçek Yaşam Verisi

    AYBU AVESIS, 2019

    Quelle: OpenAlex

  26. Kastrasyon Direncli Metastatik Prostat Kanseri (Kdmpk) Olan Geriatrik (≥75 Yas) Hastalarda 1. Basamak Dosetaksel Tedavi Sonucları- Gercek Yasam Verisi

    AYBU AVESIS, 2019

    Quelle: OpenAlex

  27. Association Between Elevated Serum Uric Acid and Vitamin D Insufficiency Among the Middle-Aged and Elderly Population

    DOAJ (DOAJ: Directory of Open Access Journals), 2019

    Frei zugänglicher VolltextQuelle: OpenAlex

  28. Skeletal muscle loss during anti-EGFR combined chemotherapy regimens predicts poor prognosis in patients with RAS wild metastatic colorectal cancer

    Clinical and Translational Oncology, 2019

    DOI 10.1007/s12094-019-02079-x PMID 30924091 4 Zitationen (Europe PMC) Quelle: ORCID

  29. Assessment of duodenal diverticula: Computed tomography findings

    Current Medical Imaging, 2019

    DOI 10.2174/1573405614666180904123526 PMID 32008522 1 Zitation (Europe PMC) Quelle: ORCID

  30. Effect of low-dose acitretin treatment on pituitary hormones in psoriasis vulgaris: A retrospective study

    Indian Journal of Dermatology, Venereology and Leprology, 2019

    DOI 10.4103/ijdvl.ijdvl_628_17 PMID 29855455 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  31. Effect of somatostatin analogs on prostate volume,Somatostatin analoglarinin prostat volümü üzerine etkisi

    Medeniyet Medical Journal, 2019

    DOI 10.5222/mmj.2019.47700 Frei zugänglicher VolltextQuelle: ORCID

  32. Prognostic importance of the albumin to globulin ratio in metastatic gastric cancer patients

    Current Medical Research and Opinion, 2019

    DOI 10.1080/03007995.2018.1479683 PMID 29785861 29 Zitationen (Europe PMC) Quelle: ORCID

  33. Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib

    Clinical and Translational Oncology, 2019

    DOI 10.1007/s12094-019-02080-4 PMID 30868388 19 Zitationen (Europe PMC) Quelle: ORCID

  34. The impact of prognostic nutritional index on coronary flow reserve in patients with inflammatory bowel disease,İnflamatuvar bağırsak hastalarında prognostik nütrisyonel indeksin koroner akım rezervi üzerine etkisi

    Medeniyet Medical Journal, 2019

    DOI 10.5222/mmj.2019.47108 PMID 32821448 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  35. Pür Seminom Vakalarının Klinik Özellikleri ve Tedavi Sonrası İzlemleri: Tek Merkez Deneyimi

    DergiPark (Istanbul University), 2019

    Frei zugänglicher VolltextQuelle: OpenAlex

  36. PÜR SEMİNOM VAKALARININ KLİNİK ÖZELLİKLERİ VE TEDAVİ SONRASI İZLEMLERİ: TEK MERKEZ DENEYİMİ

    Trakya University's Institutional Open Access System (Trakya University), 2019

    Frei zugänglicher VolltextQuelle: OpenAlex

  37. Regorafenib or rechallenge chemotherapy: which is more effective in the third-line treatment of metastatic colorectal cancer?

    Cancer Chemotherapy and Pharmacology, 2018

    DOI 10.1007/s00280-018-3713-6 PMID 30374523 13 Zitationen (Europe PMC) Quelle: OpenAlex

  38. Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes

    Cancer Chemotherapy and Pharmacology, 2018

    DOI 10.1007/s00280-018-3712-7 PMID 30377778 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  39. A retrospective study on potential drug interactions: A single center experience

    Journal of Oncological Sciences, 2018

    DOI 10.1016/j.jons.2018.06.001 7 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  40. Value of MRI apparent diffusion coefficient for assessment of response to sorafenib in hepatocellular carcinoma.

    PubMed, 2018

    PMID 30358202 3 Zitationen (Europe PMC) Quelle: OpenAlex

  41. Is serum survivin expression a predictive biomarker in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy?

    Cancer Biomarkers, 2018

    DOI 10.3233/cbm-171119 PMID 29562501 10 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  42. Assessment of cardiovascular findings in FMF related amyloid patients,Ailevi akdeniz ateşine ikincil gelişen amiloidozda kardiyovasküler bulguların değerlendirilmesi

    Medeniyet Medical Journal, 2018

    DOI 10.5222/mmj.2018.05826 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  43. BRAF V600 mutation profile of metastatic melanoma in the thrace region of Turkey

    Turk Patoloji Dergisi, 2018

    DOI 10.5146/tjpath.2018.01422 4 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  44. Endocan: a novel predictor of endothelial dysfunction in obstructive sleep apnea syndrome

    Clinical Respiratory Journal, 2018

    DOI 10.1111/crj.12487 PMID 27116287 25 Zitationen (Europe PMC) Quelle: ORCID

  45. Clinical predictive factors associated with pathologic complete response in locally advanced rectal cancer

    Journal of Oncological Sciences, 2018

    DOI 10.1016/j.jons.2017.12.004 13 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  46. K-RAS and N-RAS mutations in testicular germ cell tumors

    Bosnian Journal of Basic Medical Sciences, 2017

    DOI 10.17305/bjbms.2017.1764 PMID 28426398 20 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  47. Targeted therapy with anaplastic lymphoma kinase inhibitors in non-small cell lung cancer even with brain metastasis.

    PubMed, 2017

    PMID 28730760 2 Zitationen (Europe PMC) Quelle: OpenAlex

  48. Skin findings in autoimmune and nonautoimmune thyroid disease with respect to thyroid functional status and healthy controls

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2017

    DOI 10.3906/sag-1510-39 PMID 28618767 12 Zitationen (OpenAlex) Quelle: OpenAlex

  49. Bone mineral density and osteoporosis in hyponatremic versus normonatremic patients: A retrospective 12-month analysis

    Turkish Nephrology, Dialysis and Transplantation Journal, 2017

    DOI 10.5262/tndt.2017.1001.05 Frei zugänglicher VolltextQuelle: ORCID

  50. Chemerin as a marker of subclinical cardiac involvement in psoriatic patients

    Cardiology Journal, 2017

    DOI 10.5603/cj.a2017.0031 PMID 28353314 9 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID